main-logo

ICD-10 Code C81.3A | Lymphocyte depleted Hodgkin lymphoma, in remission Symptoms, Diagnosis, Billing

Lymphocyte depleted Hodgkin lymphoma is a rare subtype of Hodgkin lymphoma characterized by a predominance of Reed-Sternberg cells and a depletion of lymphocytes. This condition is clinically significant as it often presents with advanced disease and requires aggressive treatment. The ICD-10 Code C81.3A facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively track and manage patient outcomes.

What is ICD-10 Code C81.3A for Lymphocyte depleted Hodgkin lymphoma, in remission?

ICD-10 Code C81.3A represents Lymphocyte depleted Hodgkin lymphoma, in remission, indicating that the patient has undergone treatment and shows no active disease. This code is used when documenting the patient's clinical status post-treatment, ensuring accurate billing and continuity of care. It is essential for healthcare providers to utilize this code to reflect the patient's remission status accurately.

ICD-10 Code C81.3A – Clinical Definition and Explanation of Lymphocyte depleted Hodgkin lymphoma, in remission

Lymphocyte depleted Hodgkin lymphoma is a variant of Hodgkin lymphoma characterized by a significant reduction in lymphocytes and a predominance of Reed-Sternberg cells. This subtype is often associated with advanced disease at diagnosis and requires prompt medical intervention. The condition necessitates careful monitoring and treatment to achieve remission.

Key Clinical Features:

  • Presence of Reed-Sternberg cells in histological examination.
  • Advanced stage at diagnosis, often presenting with systemic symptoms.
  • Higher incidence in older adults and immunocompromised individuals.
  • Potential for aggressive disease course and treatment resistance.

ICD-10 Code C81.3A for Lymphocyte depleted Hodgkin lymphoma, in remission – SOAP Notes & Clinical Use

ICD-10 Code C81.3A is utilized in SOAP notes to document the patient's remission status following treatment for Lymphocyte depleted Hodgkin lymphoma. This code plays a crucial role in capturing the patient's clinical history, treatment response, and ongoing management in both acute and chronic care settings.

What Does ICD-10 Code C81.3A for Lymphocyte depleted Hodgkin lymphoma, in remission Mean in SOAP Notes?

In SOAP notes, ICD-10 Code C81.3A connects subjective patient reports and objective clinical findings to a formal diagnosis of Lymphocyte depleted Hodgkin lymphoma in remission. This code is vital for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code C81.3A – Lymphocyte depleted Hodgkin lymphoma, in remission

Management of Lymphocyte depleted Hodgkin lymphoma in remission involves ongoing monitoring and supportive care to prevent relapse. Hospitalization may be necessary for severe cases or complications.

Antibiotic Therapy:

  • Not applicable as this condition is not infectious.

Supportive Care:

  • Regular follow-up appointments for monitoring.
  • Management of treatment-related side effects.
  • Nutritional support and counseling.

Infection Control:

  • Standard precautions to prevent infections in immunocompromised patients.

How to Document Symptoms of Lymphocyte depleted Hodgkin lymphoma, in remission (ICD-10 C81.3A) in SOAP Notes

Subjective:

  • Patient reports feeling well with no new symptoms.
  • Denies fever, night sweats, or weight loss.
  • History of treatment includes chemotherapy and radiation.

Objective:

  • Physical examination shows no lymphadenopathy.
  • Vital signs stable: BP 120/80, HR 72, Temp 98.6°F.
  • Laboratory results indicate normal blood counts.
card-topcard-bottom

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more
hipaa-icon

SOAP Note Guidelines for Diagnosing Lymphocyte depleted Hodgkin lymphoma, in remission (ICD-10 Code C81.3A)

Assessment:

  • Lymphocyte depleted Hodgkin lymphoma, in remission (ICD-10 Code C81.3A).
  • Patient shows no signs of active disease.
  • Regular follow-up required to monitor for potential relapse.

Plan:

  • Continue regular follow-up every 3-6 months.
  • Educate patient on signs of relapse and when to seek care.
  • Monitor blood counts and imaging as indicated.

Treatment & Plan Section for ICD-10 Code C81.3A – Lymphocyte depleted Hodgkin lymphoma, in remission

  • Regular follow-up appointments to monitor for relapse.
  • Education on lifestyle modifications to support health.
  • Routine imaging studies as clinically indicated.
  • Psychosocial support services for emotional well-being.

Using ICD-10 Code C81.3A for Lymphocyte depleted Hodgkin lymphoma, in remission in Billing & SOAP Note Compliance

  • Ensure accurate documentation of remission status in patient records.
  • Use C81.3A in conjunction with treatment codes for comprehensive billing.
  • Document all relevant symptoms and clinical findings in SOAP notes.
  • Align treatment plans with clinical guidelines to support justified billing.

    ICD-10 Code C81.3A in Medical Billing and Insurance for Lymphocyte depleted Hodgkin lymphoma, in remission

    ICD-10 Code C81.3A is critical in medical billing, particularly in hospital and outpatient settings, to ensure accurate claims for patients in remission.

    Billing Notes:

    • Document all treatment details and patient progress to support claims.
    • Use C81.3A in conjunction with relevant CPT codes for comprehensive billing.
    • Ensure that the patient's remission status is clearly noted in the medical record.

    Common CPT Pairings:

    CPT CodeDescription
    99214Established patient office visit, moderate complexity.
    36415Collection of venous blood by venipuncture.
    85025Complete blood count with automated differential.

    Frequently Asked Questions

    Common Questions About Using ICD-10 Code C81.3A for Lymphocyte depleted Hodgkin lymphoma, in remission

    What does it mean for a patient to be in remission?

    Being in remission means that the signs and symptoms of Lymphocyte depleted Hodgkin lymphoma have significantly decreased or disappeared following treatment. This status is crucial for determining ongoing care and monitoring.

    How often should follow-up appointments occur for patients in remission?

    Patients in remission typically require follow-up appointments every 3 to 6 months to monitor for any signs of relapse and to manage any long-term effects of treatment.

    What are the common treatments for Lymphocyte depleted Hodgkin lymphoma?

    Common treatments include chemotherapy, radiation therapy, and in some cases, stem cell transplantation. The treatment plan is tailored to the individual based on disease stage and patient health.

    Is Lymphocyte depleted Hodgkin lymphoma contagious?

    No, Lymphocyte depleted Hodgkin lymphoma is not contagious. It is a type of cancer that arises from the lymphatic system and cannot be transmitted from person to person.

    diamond-bg
    diamond-bg

    Get started with your 20 free notes

    Sign up for free
    main-logo

    AI-aided Sudsy Shorthand for ink-free practices

    support@soapsuds.io
    hipaa-logo

    Clinical Notes

    SOAP notes

    DAP notes

    AI medical notes

    © Copyright SOAPsuds 2025. All rights reserved